Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012

Cell Culture & Bioprocessing Congress

05 Nov 2012 - 06 Nov 2012 - London, UK

Bookmark and Share

175 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

50 presentations, case studies and panel discussions focused on the key issues in cell line optimisation, process development and biological production

4 interactive streams:
•    Cell line development x2
•    Upstream process development
•    Biological production

14 prescheduled one to one meetings, Q&A sessions and exhibition spaces creating a unique platform for business and scientific discussion

Oxford Global Conferences are proud to present our Cell Culture & Bioprocessing Congress, taking place on 5th & 6th November, 2012 at the CBI Conference Centre in London.

Experts predict that the cell culture sector will be worth over $6 billion by 2015. The growth of the biopharma industry as whole, combined with the increasingly wide reach of cell culture applications has secured a prominent role for cell culture and bioprocessing in the pharmaceutical industry of the future.
This event is designed to offer clear and informed insights into the trends and solutions most relevant to those working in the industry. The conference programme consists of world-class keynote addresses, industry and academic led presentations and panel debates, creating an interactive platform for high-level scientific and business discussion.

On Day One, our panel of cell engineering experts will discuss vector design, genome engineering and high throughput technologies. Delegates will also hear from those working at the forefront of process innovation, in areas such as disposable reactors, next generation fermentation and process characterisation.

Day Two will feature presentations covering the critical opportunities in cell line optimisation including, miniaturised systems, 3D cell culture and bioinformatic analysis. Our highly esteemed speakers will also explore the key challenges in biological production; topics will include CMO relationship management, technology transfer and the role of single-use technology.

The Cell Culture & Bioprocessing Congress is part of the highly successful Oxford Global Proteins Series.

Further information
Scientific News
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos